Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Cencora, Inc. (COR : NYSE)
 
 • Company Description   
CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa.

Number of Employees: 46,000

 
 • Price / Volume Information   
Yesterday's Closing Price: $360.24 Daily Weekly Monthly
20 Day Moving Average: 1,375,705 shares
Shares Outstanding: 193.88 (millions)
Market Capitalization: $69,842.57 (millions)
Beta: 0.63
52 Week High: $364.36
52 Week Low: $223.92
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 14.68% 14.94%
12 Week 22.17% 17.59%
Year To Date 60.33% 40.33%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1 West First Avenue
-
Conshohocken,PA 19428
USA
ph: 610-727-7000
fax: 800-640-5221
investorrelations@cencora.com http://www.cencora.com
 
 • General Corporate Information   
Officers
Robert P. Mauch - Chief Executive Officer;President and Director
Steven H. Collis - Executive Chairman of the Board
James F. Cleary - Chief Financial Officer and Executive Vice Preside
Lazarus Krikorian - Senior Vice President and Chief Accounting Officer
D. Mark Durcan - Director

Peer Information
Cencora, Inc. (CHCR)
Cencora, Inc. (ESRX)
Cencora, Inc. (MYDP)
Cencora, Inc. (COR)
Cencora, Inc. (GBCS)
Cencora, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 03073E105
SIC: 5122
Fiscal Year
Fiscal Year End: September
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 02/04/26
Share - Related Items
Shares Outstanding: 193.88
Most Recent Split Date: 6.00 (2.00:1)
Beta: 0.63
Market Capitalization: $69,842.57 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.61%
Current Fiscal Quarter EPS Consensus Estimate: $4.01 Indicated Annual Dividend: $2.20
Current Fiscal Year EPS Consensus Estimate: $17.64 Payout Ratio: 0.14
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: -0.03
Estmated Long-Term EPS Growth Rate: 12.32% Last Dividend Paid: 08/15/2025 - $0.55
Next EPS Report Date: 02/04/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 20.43
Trailing 12 Months: 22.53
PEG Ratio: 1.66
Price Ratios
Price/Book: 39.98
Price/Cash Flow: 14.26
Price / Sales: 0.22
EPS Growth
vs. Year Ago Period: 14.97%
vs. Previous Quarter: -4.00%
Sales Growth
vs. Year Ago Period: 5.92%
vs. Previous Quarter: 3.80%
ROE
09/30/25 - 227.15
06/30/25 - 267.36
03/31/25 - 344.71
ROA
09/30/25 - 4.30
06/30/25 - 4.31
03/31/25 - 4.26
Current Ratio
09/30/25 - 0.90
06/30/25 - 0.90
03/31/25 - 0.87
Quick Ratio
09/30/25 - -
06/30/25 - 0.53
03/31/25 - 0.52
Operating Margin
09/30/25 - 0.97
06/30/25 - 0.96
03/31/25 - 0.94
Net Margin
09/30/25 - 0.48
06/30/25 - 0.60
03/31/25 - 0.55
Pre-Tax Margin
09/30/25 - 0.70
06/30/25 - 0.81
03/31/25 - 0.74
Book Value
09/30/25 - 9.01
06/30/25 - 11.40
03/31/25 - 6.09
Inventory Turnover
09/30/25 - 15.47
06/30/25 - 15.55
03/31/25 - 15.61
Debt-to-Equity
09/30/25 - 4.32
06/30/25 - 3.64
03/31/25 - 6.01
Debt-to-Capital
09/30/25 - 81.19
06/30/25 - 78.45
03/31/25 - 85.73
 

Powered by Zacks Investment Research ©